• English
  • Français
Bladder Cancer CanadaBladder Cancer CanadaBladder Cancer CanadaBladder Cancer Canada
  • Bladder Cancer
    • See Red?
    • What is Bladder Cancer?
    • Statistics and Risk Factors
    • Symptoms and Diagnosis
    • Staging and Grading
    • Types of Bladder Cancer
      • Non-Muscle Invasive Bladder Cancer
      • Muscle Invasive Bladder Cancer
      • Metastatic Bladder Cancer
      • Upper Tract Urothelial Carcinoma
    • Treatment Options
      • TURBT
      • BCG
      • Chemotherapy and Radiation
      • Bladder Removal
      • Immunotherapy
      • Bladder Preservation Options
      • Palliative Care
      • Clinical Trials
      • Advanced Bladder Cancer Treatment
    • Research and Studies
  • Patients
    • Get Support
      • Support Groups
      • One2One Peer Support
      • Online Discussion Forum
      • Contact Us by Phone or Email
    • Navigating Your Diagnosis
      • Newly Diagnosed?
      • Coping With Emotions
      • Health and Wellness Resources
      • Clinical Trials
    • Educational Resources
      • Guidebooks
      • Webinars and Videos
      • Podcast
      • Newsletter
      • Glossary
    • Upcoming Events
    • News and Stories
    • Links and Other Resources
  • Get Involved
    • Donate
    • Fundraise
    • Volunteer
    • Share Your Story
    • Patient Study Recruitment
    • Patient Self-Advocacy
    • Bladder Cancer Awareness Month
    • Your Impact
  • Health Care Practitioners
    • Doctor Resources
    • BCC Research Grant Applications
    • BCC Research Grant Recipients
    • CBCIS
    • CBCRN
    • Medical Advisory Board
  • About Us
    • Who We Are
    • Board of Directors
    • Staff
    • Medical Advisory Board
    • Sponsors and Partners
    • Financial Statements and Annual Reports
    • Newsletter
    • Contact Us
  • Walk With Us
  • Donate

Urinary Diversion Options after Bladder Removal 

    Home Blog Urinary Diversion Options after Bladder Removal 
    NextPrevious

    Urinary Diversion Options after Bladder Removal 

    By Bladder Cancer Canada | Blog, Latest news and stories | 8 October, 2024 | 0

    For the majority of patients with muscle invasive bladder cancer, treatment involves a radical cystectomy — a major surgery to remove the bladder and create a new way for urine to exit the body. This alternative method is known as a “urinary diversion.” In Canada, the three most common types of urinary diversions are the ileal conduit, neobladder, and Indiana pouch. 

    Understanding Urinary Diversions 

    The three most common urinary diversions — the ileal conduit, neobladder, and Indiana pouch — each come with distinct characteristics. The most suitable option depends on factors such as a patient’s overall health, lifestyle, and risk tolerance. Deciding on the right diversion is a highly personalized choice, often made in consultation with a healthcare provider who will help weigh the pros and cons of each method. 

    We provide a detailed explanation of these three diversions, including their advantages and disadvantages, here. 

    Bladder Cancer Canada has also developed a Radical Cystectomy Guidebook, written by patients, for patients, which offers clear and accessible information about this procedure. 

    Additionally, we hosted an informative webinar that explores the different urinary diversions, featuring insights from individuals who live with each option. You can watch the full webinar here.

    Canadian Urinary Diversions Position Statement 

    This position statement outlines best clinical practices for the pre- and postoperative care of patients undergoing a urinary diversion. Developed in collaboration with the Canadian Urological Association, Nurses Specialized in Wound, Ostomy and Continence Canada, and the Urology Nurses of Canada, it provides comprehensive guidance on managing patients through this process. 

    Pages 7-8 include a useful chart that compares the different diversions, outlining key considerations for selection and common complications.

    Copyright Canadian Urological Association. Image sourced from: https://www.cua.org/program/13306 

    Support Before and After Surgery 

    No matter which urinary diversion method you choose, adjusting to life after a radical cystectomy can be a significant transition. Patients may face both physical and emotional challenges, but there are many resources to help you along the way: 

    • Radical Cystectomy Guidebook: This guidebook covers everything you need to know before, during, and after surgery, including detailed explanations of the urinary diversion options.  
    • One2One Peer Support Program:  Connect with trained volunteers who have firsthand experience with different diversions. They can provide guidance and answer any questions you may have. 
    • Support Groups: Join our support groups—whether in- person or online—to connect with others, share experiences, and ask questions in a welcoming, non-judgmental environment. 
    • Online Discussion Forum: Our secure, confidential forum allows you to engage with the bladder cancer community at any time. Whether you prefer to browse existing posts or actively participate, the option to remain anonymous is available. 
    • Disability Tax Credit: The Disability Tax Credit (DTC) is a non-refundable tax credit that helps people with disabilities, or their supporting family member, reduce the amount of income tax they may have to pay to offset some of the costs related to their condition. We created a helpful guide, the Disability Tax Credit (DTC) for Medical Professionals, which provides guidance on how to complete “Part B: Medical Practitioner’s Section” of the DTC Certificate. 

    Facing a radical cystectomy can feel overwhelming, but understanding your options and accessing the right resources can make the transition smoother. From choosing a urinary diversion to adjusting to life after surgery, each patient’s journey is unique. 

    Bladder Cancer Canada is here to support you every step of the way. If you have questions or need further assistance, do not hesitate to contact us at info@bladdercancercanada.org or 1-866-674-8889. We’re here to help! 

    No tags.

    Related Post

    • Volunteer’s personal approach leads to deeper commitment from corporate supporter

      By Bladder Cancer Canada | 0 comment

      By: Tom Eremondi Read time: 3.5 minutes Admittedly old school, Gerry Ross’ approach to dealing with a local walk sponsor nurtured and enhanced the relationship to a surprising level. This story, however, dates back aboutRead more

    • “The risk of recurrence of my cancer is high, so I need to take care of myself.”

      By Bladder Cancer Canada | 0 comment

      Read time: 2 minutes We were so pleased to see one of our new Peer Support Volunteers, Gervais  Fournier, featured in this New Normal, Same Cancer news story, seen last month in the Le JournalRead more

    • This May, we’re making bladder cancer impossible to ignore! 

      By Bladder Cancer Canada | Comments are Closed

      Subscribe today! Our May newsletter is filled with lots of initiatives to create awareness for bladder cancer including blogs, podcasts, helpful facts, webinars and more. Bladder cancer is the 5th most common cancer in Canada andRead more

    • Bladder cancer & COVID-19 FAQ

      By Bladder Cancer Canada | Comments are Closed

      Uncertain times are upon us, around the world, as we globally respond to the coronavirus (COVID-19) that is affecting us all on some level. Many members of our bladder cancer community are directing questions our way aboutRead more

    • Protecting Yourself During the Coronavirus Outbreak

      By Bladder Cancer Canada | Comments are Closed

      (The following content is sourced from various sites advising on the coronavirus. For more information, please see the end of this article for additional resources. Photo Credit: CDC) As news of the coronavirus (COVID-19) continues toRead more

    • Health Canada Approves BALVERSA

      By Bladder Cancer Canada | Comments are Closed

      In a recent press release, Janssen Pharmaceutical Companies of Johnson & Johnson have announced that they have received approval from Health Canada for BALVERSA™ (erdafitinib), the first FGFR Kinase inhibitor for the treatment of patientsRead more

    • Announcing the Launch of Our New Hematuria Brochure: A Vital Resource for Early Bladder Cancer Detection 

      By Bladder Cancer Canada | Comments are Closed

      We have developed this easy-to-understand resource aimed at increasing awareness of hematuria.

    • Our First Annual Research Report Is Live! 

      By Bladder Cancer Canada | Comments are Closed

      Our first Annual Research Report brings you exciting updates from the world of bladder cancer research.

    • Tax Season is Upon Us! 

      By Bladder Cancer Canada | Comments are Closed

      Spring has sprung and so has tax season! Don’t miss out on valuable credits or deductions! 

    • Patient Story: Stéphanie

      By Bladder Cancer Canada | Comments are Closed

      My life turned upside down with the announcement of a bladder cancer diagnosis.

    • Join us for an Education Event in Vancouver this May! 

      By Bladder Cancer Canada | Comments are Closed

      Bladder Cancer Canada is thrilled to be hosting a special education event in Vancouver!

    NextPrevious

    Recent Blog Posts

    • Announcing the Launch of Our New Hematuria Brochure: A Vital Resource for Early Bladder Cancer Detection 
    • Our First Annual Research Report Is Live! 
    • Economic Impacts of a Cancer Diagnosis on Canadians
    • Tax Season is Upon Us! 
    • Happy National Volunteer Week 2025!

    Upcoming Events

    • Outreach Events
    • In-person Education Events
    • Support Groups
    • Webinars

    Blog Categories

    • Blog
    • Honouring our volunteers
    • Latest news and stories
    • Patient Stories
    • Upcoming meeting and events
    • Volunteers
    • Webinar

    Bladder Cancer Canada

    4936 Yonge Street, Suite 1000, Toronto, ON M2N 6S3
    Phone: 1-866-674-8889
    Email & Media Contact: info@bladdercancercanada.org

    Privacy Policy | Donor Bill of Rights

    Charitable Reg No. 83612 6060 RR0001

    © Bladder Cancer Canada.

    SUBSCRIBE TO OUR NEWSLETTER
    SEND US A MESSAGE
    • Bladder Cancer
      • See Red?
      • What is Bladder Cancer?
      • Statistics and Risk Factors
      • Symptoms and Diagnosis
      • Staging and Grading
      • Types of Bladder Cancer
        • Non-Muscle Invasive Bladder Cancer
        • Muscle Invasive Bladder Cancer
        • Metastatic Bladder Cancer
        • Upper Tract Urothelial Carcinoma
      • Treatment Options
        • TURBT
        • BCG
        • Chemotherapy and Radiation
        • Bladder Removal
        • Immunotherapy
        • Bladder Preservation Options
        • Palliative Care
        • Clinical Trials
        • Advanced Bladder Cancer Treatment
      • Research and Studies
    • Patients
      • Get Support
        • Support Groups
        • One2One Peer Support
        • Online Discussion Forum
        • Contact Us by Phone or Email
      • Navigating Your Diagnosis
        • Newly Diagnosed?
        • Coping With Emotions
        • Health and Wellness Resources
        • Clinical Trials
      • Educational Resources
        • Guidebooks
        • Webinars and Videos
        • Podcast
        • Newsletter
        • Glossary
      • Upcoming Events
      • News and Stories
      • Links and Other Resources
    • Get Involved
      • Donate
      • Fundraise
      • Volunteer
      • Share Your Story
      • Patient Study Recruitment
      • Patient Self-Advocacy
      • Bladder Cancer Awareness Month
      • Your Impact
    • Health Care Practitioners
      • Doctor Resources
      • BCC Research Grant Applications
      • BCC Research Grant Recipients
      • CBCIS
      • CBCRN
      • Medical Advisory Board
    • About Us
      • Who We Are
      • Board of Directors
      • Staff
      • Medical Advisory Board
      • Sponsors and Partners
      • Financial Statements and Annual Reports
      • Newsletter
      • Contact Us
    • Walk With Us
    • Donate
    Bladder Cancer Canada